Clinical presentation, prognostic factors and treatment outcome of multiple myeloma (MM) in African American (AA) patients.

被引：0
|
作者：
Badros, Ashraf Z. [1 ]
Goloubeva, Olga [1 ]
Chumsri, Saranya [1 ]
Ruehle, Kathleen [1 ]
Ning, Yi [1 ]
Meekins, Joann [1 ]
Guedez, Liliana [1 ]
Rapoport, Aaron P. [1 ]
Meisenberg, Barry [1 ]
Akpek, Gorgon [1 ]
Yanovich, Saul [1 ]
Sausville, Edward [1 ]
机构：
[1] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5024
引用
收藏
页码：345B / 345B
页数：1
相关论文
共 50 条
  • [31] Frequent alteration of the IkB gene in multiple myeloma (MM) patients.
    Ma, HJ
    Parker, KM
    Altamirano, CV
    Mikail, AE
    Glowalla, A
    Vescio, R
    Berenson, JR
    BLOOD, 2000, 96 (11) : 678A - 678A
  • [32] Immunoglobulin D Multiple Myeloma: Clinical Presentation, Response to Therapy and Prognostic Factors in 75 Patients; An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).
    Kim, Min Kyoung
    Suh, Cheolwon
    Min, Chang-Ki
    Kim, Seok Jin
    Kim, Kihyun
    Moon, Joon Ho
    Yoon, Sung-Soo
    Lee, Gyeong-Won
    Kang, Hye Jin
    Kim, Sung Hyun
    Choi, Chul Won
    Eom, Hyeon Seok
    Kwak, Jae-Yong
    Kim, Hyo Jung
    Mun, Yeung-Chul
    Bang, Soo-Mee
    Lee, Keehyun
    Shin, Ho Jin
    Yang, Deok Hwan
    Lee, Jae Hoon
    BLOOD, 2009, 114 (22) : 712 - 713
  • [33] Predictive factors in peripheral blood stem cell (PBSC) harvest in multiple myeloma (MM) patients.
    Worel, N
    Schlogl, E
    Rabitsch, W
    Kuhrer, I
    Greinix, H
    Hocker, P
    BLOOD, 1997, 90 (10) : 4272 - 4272
  • [34] Pre-treatment differences between HCV-infected African American (AA) and non-African American patients.
    Wiley, TE
    Mika, BP
    McCarthy, ME
    Layden, TJ
    HEPATOLOGY, 1999, 30 (04) : 265A - 265A
  • [35] Intensive consolidation therapy after tandem transplants further improves the outcome of multiple myeloma (MM) patients.
    Desikan, R
    Fassas, A
    Munshi, N
    Badros, A
    Zangari, M
    Toor, A
    Morris, C
    Barlogie, B
    Tricot, G
    BLOOD, 2000, 96 (11) : 169A - 169A
  • [36] Comparative Analysis of Clinical Trial Outcomes between African American and White Patients Treated with Lenalidomide and Dexamethasone for Multiple Myeloma (MM)
    Ailawadhi, Sikander
    Larkins, Gail
    Chung, Weiyuan
    Srinivasan, Shankar
    Agarwal, Amit
    BLOOD, 2017, 130
  • [37] Characteristics and Outcome Of Multiple Myeloma (MM) In African Americans (AA) Receiving Novel Agents and Autologous Stem Cell Transplantation (ASCT)
    Bhatnagar, Vishal
    Wu, Yin
    Goloubeva, Olga
    Ruehle, Kathleen
    Milliron, Todd
    Yanovich, Saul
    Rapoport, Aaron P.
    Badros, Ashraf
    BLOOD, 2013, 122 (21)
  • [38] Prognostic Value of PINI in Elderly Patients with Multiple Myeloma (MM)
    Dupire, Sophie
    Debarri, Houria
    Pascal, Laurent
    Coiteux, Valerie
    Hivert, Benedicte
    Willekens, Christophe
    Rossignol, Julien
    Yakoub-Agha, Ibrahim
    Onraed, Brigitte
    Faucompre, Jean-Luc
    Hennache, Bernadette
    Dumontet, Charles
    Facon, Thierry
    Leleu, Xavier
    BLOOD, 2009, 114 (22) : 983 - 984
  • [39] Clinical characteristics, treatment patterns, and outcomes among African American and White patients with multiple myeloma in the United States
    Saunders, Ashley
    Slaff, Samantha
    Subbiah, Krishnaveni
    Gu, Tao
    Ang, Kwan-Keat
    Quan, Michelle Alyssa
    Rosenberg, Aaron Seth
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 109 - 117
  • [40] Malignant pleural effusion of multiple myeloma: Prognostic factors and outcome
    Kamble, R
    Wilson, CS
    Fassas, A
    Desikan, R
    Siegel, DS
    Tricot, G
    Anderson, P
    Sawyer, J
    Anaissie, E
    Barlogie, B
    LEUKEMIA & LYMPHOMA, 2005, 46 (08) : 1137 - 1142
12345